Scientists Meet in Valencia to Define the Path to Clinical Integration Valencia, Spain. June 9–10, 2026 Researchers, clinicians, and biotechnology innovators from around the world will gather in ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

You will be redirected to our submission process. Cancer biology increasingly recognizes that cancer stem cells (CSCs) represent a critical subpopulation within tumors, marked by their self-renewal, ...